Loading...
Biofrontera Inc.
BFRI•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.06
$-0.04(-4.07%)
Biofrontera Inc. (BFRI) Financial Performance & Income Statement Overview
Review Biofrontera Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
9.49%
↑ 9.49%
Operating Income Growth
24.11%
↑ 24.11%
Net Income Growth
11.78%
↑ 11.78%
Operating Cash Flow Growth
58.75%
↑ 58.75%
Operating Margin
-42.88%
↓ 42.88%
Gross Margin
55.29%
↑ 55.29%
Net Profit Margin
-30.34%
↓ 30.34%
ROE
-216.00%
↓ 216.00%
ROIC
-289.39%
↓ 289.39%
Biofrontera Inc. (BFRI) Income Statement & Financial Overview
Review Biofrontera Inc.'s (BFRI) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $12.55M | $9.01M | $7.84M | $7.90M |
| Cost of Revenue | $4.69M | $4.88M | $4.34M | $3.95M |
| Gross Profit | $7.86M | $4.13M | $3.50M | $3.96M |
| Gross Profit Ratio | $0.63 | $0.46 | $0.45 | $0.50 |
| R&D Expenses | $782000.00 | $669000.00 | $621000.00 | $17000.00 |
| SG&A Expenses | $8.17M | $8.43M | $7.95M | $9.25M |
| Operating Expenses | $9.58M | $9.10M | $8.57M | $9.43M |
| Total Costs & Expenses | $14.27M | $13.97M | $12.91M | $13.38M |
| Interest Income | -$55000.00 | $17000.00 | $24000.00 | $14000.00 |
| Interest Expense | -$4.08M | $9000.00 | $620000.00 | $1.42M |
| Depreciation & Amortization | -$928000.00 | $312000.00 | $309000.00 | $307000.00 |
| EBITDA | -$6.41M | -$5.34M | $692000.00 | -$8.71M |
| EBITDA Ratio | -$0.51 | -$0.59 | $0.09 | -$1.10 |
| Operating Income | -$1.71M | -$4.96M | -$5.07M | -$5.47M |
| Operating Income Ratio | -$0.14 | -$0.55 | -$0.65 | -$0.69 |
| Other Income/Expenses (Net) | $314000.00 | -$706000.00 | $4.83M | -$4.97M |
| Income Before Tax | -$1.40M | -$5.67M | -$237000.00 | -$10.44M |
| Income Before Tax Ratio | -$0.11 | -$0.63 | -$0.03 | -$1.32 |
| Income Tax Expense | -$2000.00 | $3000.00 | $20000.00 | $1000.00 |
| Net Income | -$1.40M | -$5.67M | -$257000.00 | -$10.44M |
| Net Income Ratio | -$0.11 | -$0.63 | -$0.03 | -$1.32 |
| EPS | $2.97 | -$0.98 | -$0.05 | -$2.88 |
| Diluted EPS | $2.97 | -$0.98 | -$0.05 | -$2.88 |
| Weighted Avg Shares Outstanding | $5.52B | $5.77B | $5.09B | $3.62B |
| Weighted Avg Shares Outstanding (Diluted) | $5.52B | $5.77B | $5.09B | $3.62B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan